|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||
| Restricted cash | ||||||||||||||||||
| Due from Cycurion- promissory note | ||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||
| Note receivable - WAVS | ||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||
| Other receivables | ||||||||||||||||||
| Sponsor | ||||||||||||||||||
| Total other receivables | ||||||||||||||||||
| Total current assets | ||||||||||||||||||
| Deferred offering costs | ||||||||||||||||||
| Deposit for acquisition target | ||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||
| Software development costs | ||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||
| Security deposits | ||||||||||||||||||
| Software development costs, net | ||||||||||||||||||
| Goodwill and intangibles | ||||||||||||||||||
| Investments held in trust account | ||||||||||||||||||
| Total non-current assets | ||||||||||||||||||
| Total assets | ||||||||||||||||||
| Liabilities and Stockholders' Equity: | ||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||
| Due to Trust Account | ||||||||||||||||||
| Loan payable | ||||||||||||||||||
| Liabilities: | ||||||||||||||||||
| Bank loan-revolving credit line | ||||||||||||||||||
| Loans payable | ||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||
| Related Party | ||||||||||||||||||
| Total loans payable | ||||||||||||||||||
| Bank loan - current portion | ||||||||||||||||||
| Loans Payable- current portion/ related parties | ||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||
| Related Party | ||||||||||||||||||
| Total notes payable | ||||||||||||||||||
| Factoring liability | ||||||||||||||||||
| Subordinated convertible promissory notes | ||||||||||||||||||
| Convertible notes | ||||||||||||||||||
| Promissory notes | ||||||||||||||||||
| Accounts payable | ||||||||||||||||||
| Due to related party | ||||||||||||||||||
| Sponsor | ||||||||||||||||||
| Related Party | ||||||||||||||||||
| Total due to related party | ||||||||||||||||||
| Derivative liability-Forward Purchase Agreement | ||||||||||||||||||
| Deferred revenue | ||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||
| Income Tax Payable | ||||||||||||||||||
| Franchise tax payable | ||||||||||||||||||
| Accrued compensation and benefits | ||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||
| Excise tax payable | ||||||||||||||||||
| Total current liabilities | ||||||||||||||||||
| Loans payable - non-current portion | ||||||||||||||||||
| Series A Convertible preferred stock ($0.001 par value, 500,000 shares designated, 0 and 345,528 issued and outstanding, respectively) | ||||||||||||||||||
| Series A convertible preferred stock ($0.001 par value, 16,667 shares designated, 0 and 11,518 issued and outstanding, respectively) | ||||||||||||||||||
| Total non-current liabilities | ||||||||||||||||||
| Total liabilities | ||||||||||||||||||
| Common stock subject to possible redemption, $0.0001 par value, 0 and 5,796 shares at redemption value of approximately $11.03 per share, respectively | ||||||||||||||||||
| Common stock subject to possible redemption | ||||||||||||||||||
| Total common stock subject to possible redemption, $0.0001 par value, 0 and 5,796 shares at redemption value of approximately $11.03 per share, respectively | ||||||||||||||||||
| Stockholders' Equity: | ||||||||||||||||||
| Preferred stock, value, issued | ||||||||||||||||||
| Series A Convertible Preferred Stock | ||||||||||||||||||
| Series D Convertible Preferred Stock | ||||||||||||||||||
| Series A Convertible Preferred Stock | ||||||||||||||||||
| Series B Convertible Preferred Stock | ||||||||||||||||||
| Series C Convertible Preferred Stock | ||||||||||||||||||
| Series D Convertible Preferred Stock | ||||||||||||||||||
| Series E Convertible Preferred Stock | ||||||||||||||||||
| Series F Convertible Preferred Stock | ||||||||||||||||||
| Series G Convertible Preferred Stock | ||||||||||||||||||
| Series H Convertible Preferred Stock | ||||||||||||||||||
| Series I Convertible Preferred Stock | ||||||||||||||||||
| Common stock ($0.0001 par value, 300,000,000 shares authorized, 3,642,468 and 391,338 shares issued and outstanding, respectively) | ||||||||||||||||||
| Previously Reported | ||||||||||||||||||
| Total common stock ($0.0001 par value, 300,000,000 shares authorized, 3,642,468 and 391,338 shares issued and outstanding, respectively) | ||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||
| Previously Reported | ||||||||||||||||||
| Total additional paid in capital | ||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||
| Total stockholders' equity attributable to Cycurion | ||||||||||||||||||
| Deficit attributable to noncontrolling interests | ||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||
Loading...
